Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IMspire170: New combination treatment for advanced melanoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.10.19
Views: 575

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

Dr Ana Arance speaks to ecancer at ESMO 2019 in Barcelona about the IMspire170 trial for advanced melanoma.

She explains the study design and how the study did not reach the primary endpoint.

Dr Arance outlines some of the reasons why this could be the case, and what areas need to be looked at in more detail.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation